Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Change in Accured Expenses (2022 - 2025)

Historic Change in Accured Expenses for CervoMed (CRVO) over the last 9 years, with Q3 2025 value amounting to $454084.0.

  • CervoMed's Change in Accured Expenses fell 5837.68% to $454084.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 90.66%. This contributed to the annual value of $690290.0 for FY2024, which is 4644.86% down from last year.
  • According to the latest figures from Q3 2025, CervoMed's Change in Accured Expenses is $454084.0, which was down 5837.68% from $713608.0 recorded in Q2 2025.
  • In the past 5 years, CervoMed's Change in Accured Expenses registered a high of $1.1 million during Q3 2024, and its lowest value of -$440808.0 during Q2 2022.
  • Its 4-year average for Change in Accured Expenses is $205149.7, with a median of $203906.0 in 2024.
  • Per our database at Business Quant, CervoMed's Change in Accured Expenses surged by 119612.38% in 2023 and then crashed by 17365.43% in 2024.
  • Over the past 4 years, CervoMed's Change in Accured Expenses (Quarter) stood at $158332.0 in 2022, then surged by 272.64% to $590016.0 in 2023, then plummeted by 65.44% to $203906.0 in 2024, then skyrocketed by 122.69% to $454084.0 in 2025.
  • Its Change in Accured Expenses stands at $454084.0 for Q3 2025, versus $713608.0 for Q2 2025 and -$285439.0 for Q1 2025.